1. Home
  2. AXSM vs HUN Comparison

AXSM vs HUN Comparison

Compare AXSM & HUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXSM
  • HUN
  • Stock Information
  • Founded
  • AXSM 2012
  • HUN 1970
  • Country
  • AXSM United States
  • HUN United States
  • Employees
  • AXSM N/A
  • HUN N/A
  • Industry
  • AXSM Biotechnology: Pharmaceutical Preparations
  • HUN Major Chemicals
  • Sector
  • AXSM Health Care
  • HUN Industrials
  • Exchange
  • AXSM Nasdaq
  • HUN Nasdaq
  • Market Cap
  • AXSM 5.1B
  • HUN 2.4B
  • IPO Year
  • AXSM 2015
  • HUN 2005
  • Fundamental
  • Price
  • AXSM $102.65
  • HUN $11.05
  • Analyst Decision
  • AXSM Strong Buy
  • HUN Hold
  • Analyst Count
  • AXSM 16
  • HUN 9
  • Target Price
  • AXSM $170.50
  • HUN $15.00
  • AVG Volume (30 Days)
  • AXSM 719.8K
  • HUN 3.6M
  • Earning Date
  • AXSM 08-04-2025
  • HUN 08-04-2025
  • Dividend Yield
  • AXSM N/A
  • HUN 9.07%
  • EPS Growth
  • AXSM N/A
  • HUN N/A
  • EPS
  • AXSM N/A
  • HUN N/A
  • Revenue
  • AXSM $432,157,000.00
  • HUN $5,976,000,000.00
  • Revenue This Year
  • AXSM $62.84
  • HUN N/A
  • Revenue Next Year
  • AXSM $60.02
  • HUN $5.10
  • P/E Ratio
  • AXSM N/A
  • HUN N/A
  • Revenue Growth
  • AXSM 72.16
  • HUN 0.02
  • 52 Week Low
  • AXSM $72.21
  • HUN $10.13
  • 52 Week High
  • AXSM $139.13
  • HUN $25.12
  • Technical
  • Relative Strength Index (RSI)
  • AXSM 48.53
  • HUN 38.56
  • Support Level
  • AXSM $99.75
  • HUN $10.30
  • Resistance Level
  • AXSM $106.60
  • HUN $10.69
  • Average True Range (ATR)
  • AXSM 3.11
  • HUN 0.36
  • MACD
  • AXSM 0.10
  • HUN 0.01
  • Stochastic Oscillator
  • AXSM 44.39
  • HUN 14.25

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

About HUN Huntsman Corporation

Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Advanced Materials. It derives the majority of its revenue from the Polyurethanes segment,t which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.

Share on Social Networks: